Medical Design Technology -
11 Aug 2016 15:59
News A method for "silencing" RNA that emerged from a University of Wisconsin-Madison spinoff company is in clinical trials in Europe, Asia and the United States against hepatitis B. Contributed Author: University of Wisconsin-Madison Topics: Medical Diagnostics
Share this Article